This article is a correction to:
SPOCK1 Promotes the Development of Hepatocellular Carcinoma
Lóránd Váncza1
Katalin Karászi1Bálint Péterfia2
Lilla Turiák3
Katalin Dezső1Anna Sebestyén1
Andrea Reszegi1
Gábor Petővári1András Kiss4
Zsuzsanna Schaff4
Kornélia Baghy1
Ilona Kovalszky1*- 11st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
- 2Faculty of Information Technology and Bionics, Pázmány Péter Catholic University, Budapest, Hungary
- 3MS Proteomics Research Group, Research Centre for Natural Sciences, EötvösLoránd Research Network, Budapest, Hungary
- 42nd Department of Pathology, Semmelweis University, Budapest, Hungary
A corrigendum on
SPOCK1 promotes the development of hepatocellular carcinoma
by Váncza L, Karászi K, Péterfia B, Turiák L, Dezső K, Sebestyén A, Reszegi A, Petővári G, Kiss A, Schaff Z, Baghy K and Kovalszky I (2022) Front. Oncol. 12:819883. doi: 10.3389/fonc.2022.819883
In the published article, there was an error in the Funding statement. The Funding statement for the Hungarian Scientific Research Fund was displayed as “(grants 67925, 100904 and 119283 to IK and FK 138673 to KD)”. The correct Funding statement appears below.
This work was supported by the Hungarian Scientific Research Fund (grants 67925, 100904 and 119283 to IK; FK 138673 to KD and FK 138593 to KB) and European Union Horizon 2020 Marie Skłodowska-Curie Actions (MSCA) Research and Innovation Staff Exchange Evaluations (RISE) project (grant 645756): “GLYCANC—Matrix glycans as multifunctional pathogenesis factors and therapeutic targets in cancer” (to IK and KB), EFOP-3.6.3-VEKOP-16-2017-00009 (to LV).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: hepatocellular cancer (HCC), SPOCK1 in the liver, SPOCK1 and syndecan-1, SPOCK1 in mitochondrion, effect of SPOCK1 inhibition and overexpression
Citation: Váncza L, Karászi K, Péterfia B, Turiák L, Dezső K, Sebestyén A, Reszegi A, Petővári G, Kiss A, Schaff Z, Baghy K and Kovalszky I (2023) Corrigendum: SPOCK1 promotes the development of hepatocellular carcinoma. Front. Oncol. 13:1203745. doi: 10.3389/fonc.2023.1203745
Received: 11 April 2023; Accepted: 12 April 2023;
Published: 19 April 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Váncza, Karászi, Péterfia, Turiák, Dezső, Sebestyén, Reszegi, Petővári, Kiss, Schaff, Baghy and Kovalszky. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ilona Kovalszky, kovalszky.ilona@med.semmelweis-univ.hu; kovalelastic@gmail.com